Back
Protalix BioTherapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
68
PLX
Protalix BioTherapeutics
Last Price:
1.27
Seasonality Move:
64.55%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.13 | Buy |
| 20-day SMA: | 1.08 | Buy |
| 50-day SMA: | 1.05 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 1.15 | Buy |
| 20-day EMA: | 1.1 | Buy |
| 50-day EMA: | 1.08 | Buy |
| 200-day EMA: | 1.2 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 71.81 | Buy |
| Chaikin Money Flow: | 221052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.13) | Buy |
| Bollinger Bands (100): | (1 - 1.16) | Buy |
Protalix BioTherapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.25 while PLX 8-day simple moving average is 1.13, which is a Buy signal.
- The stock price of PLX is 1.25 while Protalix BioTherapeutics 20-day SMA is 1.08, which makes it a Buy.
- Protalix BioTherapeutics 50-day simple moving average is 1.05 while PLX share price is 1.25, making it a Buy technically.
- PLX stock price is 1.25 and Protalix BioTherapeutics 200-day simple moving average is 1.19, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
68
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Buy
The current Protalix BioTherapeutics [PLX] share price is $1.25. The Score for PLX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
91.93M
Price in USD:
1.25
Share Volume:
294.74K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.90
52-Week Low:
0.82
Buy
68
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.25 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.25 while PLX 8-day exponential moving average is 1.15, which is a Buy signal.
- The stock price of PLX is 1.25 while Protalix BioTherapeutics 20-day EMA is 1.10, which makes it a Buy.
- Protalix BioTherapeutics 50-day exponential moving average is 1.08 while PLX share price is 1.25, making it a Buy technically.
- PLX stock price is 1.25 and Protalix BioTherapeutics 200-day simple moving average is 1.20, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Protalix BioTherapeutics is a Buy
- Protalix BioTherapeutics Relative Strength Index (RSI) is 71.81, which suggest Protalix BioTherapeutics is overbought
- The Bollinger Bands (25) for Protalix BioTherapeutics is (1.01 - 1.13), which suggest Protalix BioTherapeutics is a Buy
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1 - 1.16), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.